Changes in Peritoneal Coagulation and Fibrinolysis after Discontinuation of Chronic Peritoneal Dialysis

♦ Objectives To study changes in peritoneal function after transfer from chronic peritoneal dialysis (CPD) to hemodialysis (HD), especially the effects on peritoneal coagulation, fibrinolytic markers, and mesothelium. ♦ Design Prospective observational study. ♦ Setting A tertiary-care university hospital. ♦ Patients Nine patients who transferred from CPD to HD were enrolled in the study after giving fully informed consent. ♦ Methods After transfer to HD, the peritoneal cavity was lavaged with low glucose PD solution once per day through PD catheters left in place. Thrombin–antithrombin III complex (TAT) was measured serially as a marker of peritoneal coagulation. As fibrinolytic markers, fibrinogen/fibrin degradation products (FDP) and plasmin–α2-antiplasmin complex (PIC) were assessed. Cancer antigen 125 (CA125) was measured as a marker of mesothelial cell mass. ♦ Results Levels of peritoneal TAT and FDP were much higher than plasma levels, indicating high local fibrin turnover. Transfer to HD induced a significant fall in mean peritoneal TAT, from 115.8 ± 52.1 to 60.7 ± 21.8 ng/mL, p < 0.05. Except for 1 patient with a 20-fold increase, mean peritoneal FDP decreased significantly, from 43.6 ± 11.1 to 19.6 ± 3.5 μg/mL, p < 0.05. Mean peritoneal PIC increased significantly, from 1.9 ± 0.4 to 3.9 ± 0.6 μg/mL, p < 0.05. Peritoneal CA125 increased from 156.4 ± 57.3 to 1426.2 ± 389.4 U/mL, p < 0.05. ♦ Conclusions Peritoneal fibrin turnover was accelerated on CPD and stabilized after transfer to HD. Transfer to HD also induced mesothelial regeneration.

[1]  M. Kamm Challenges in functional bowel disease. , 2001, The European journal of surgery. Supplement. : = Acta chirurgica. Supplement.

[2]  J. Małyszko,et al.  Comparison of Hemostatic Disturbances between Patients on Capd and Patients on Hemodialysis , 2001, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[3]  S. Mujais,et al.  Encapsulating Peritoneal Sclerosis: Definition, Etiology, Diagnosis, and Treatment , 2000, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[4]  R. Krediet The peritoneal membrane in chronic peritoneal dialysis. , 1999, Kidney international.

[5]  C. Hawley,et al.  Sclerosing peritonitis: the experience in Australia. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[6]  U. Binswanger,et al.  Is Heparin Therapy Necessary in Capd Peritonitis? , 1997, Peritoneal Dialysis International.

[7]  T. V. van Gulik,et al.  Peritoneal Sclerosis in Chronic Peritoneal Dialysis Patients: Analysis of Clinical Presentation, Risk Factors, and Peritoneal Transport Kinetics , 1997, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[8]  D. Struijk,et al.  Longitudinal follow-up of CA125 in peritoneal effluent. , 1997, Kidney international.

[9]  M. Spannagl,et al.  Coagulation and Fibrinolysis-Related Antigens in Plasma and Dialysate of Capd Patients , 1997, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[10]  B. Risberg,et al.  Plasminogen activators and inhibitors in peritoneal tissue , 1997, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[11]  M. Rabau,et al.  [Intraperitoneal adhesions]. , 1997, Harefuah.

[12]  L. Holmdahl The role of fibrinolysis in adhesion formation. , 1997, The European journal of surgery. Supplement. : = Acta chirurgica. Supplement.

[13]  T. Sakai,et al.  Prognosis for patients with sclerosing encapsulating peritonitis following CAPD. , 1997, Advances in peritoneal dialysis. Conference on Peritoneal Dialysis.

[14]  Y. Kawaguchi,et al.  Sclerosing encapsulating peritonitis in patients undergoing continuous ambulatory peritoneal dialysis: a report of the Japanese Sclerosing Encapsulating Peritonitis Study Group. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[15]  J. van der Meer,et al.  Coagulation and fibrinolytic responses of human peritoneal fluid and plasma to bacterial peritonitis , 1996, The British journal of surgery.

[16]  D. Struijk,et al.  Dialysate CA125 in stable CAPD patients: no relation with transport parameters. , 1995, Clinical Nephrology.

[17]  D. Zemel,et al.  Dialysate Markers of Peritoneal Tissue during Peritonitis and in Stable CAPD , 1995, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[18]  T. Kooistra,et al.  Imbalance between intraperitoneal coagulation and fibrinolysis during peritonitis of CAPD patients: the role of mesothelial cells. , 1995, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[19]  C. Visser,et al.  Cancer antigen 125: a bulk marker for the mesothelial mass in stable peritoneal dialysis patients. , 1995, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[20]  J. Dobbie Pathogenesis of Peritoneal Fibrosing Syndromes (Sclerosing Peritonitis) in Peritoneal Dialysis , 1992, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[21]  T. Kooistra,et al.  Characterization and fibrinolytic properties of human omental tissue mesothelial cells. Comparison with endothelial cells. , 1990, Blood.

[22]  Z. Twardowski Clinical value of standardized equilibration tests in CAPD patients. , 1989, Blood purification.